tradmap

PAVM Earnings PAVmed Inc.

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated

Annual results

Diluted EPS (annual)
-$15 -$0 $15 $0 2022 2023 2024 2025
EPS
Revenue (annual)
$0 $1M $3M 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Revenue
Net income (annual)
-$89M -$29M $32M $0 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Net income

Quarterly results

Diluted EPS (quarterly)
-$7 $1 $10 $0 Q3 '22 Q2 '23 Q1 '24 Q3 '24 Q2 '25 Q1 '26
EPS
Revenue (quarterly)
$0 $524500 $1M Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Revenue
Net income (quarterly)
-$18M $23M $64M $0 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Net income

Reported EPS history

1–17 of 17
Q2 20262026-06-30-3.172026-08-1310-Q
Q1 20262026-03-31-4.422026-05-1410-Q
FY 20252025-12-31-5.632026-03-2710-K
Q3 20252025-09-30-0.112025-11-1210-Q
Q2 20262025-06-303.942026-08-1310-Q
Q1 20262025-03-3110.102026-05-1410-Q
FY 20252024-12-3114.902026-03-2710-K
Q3 20252024-09-300.792025-11-1210-Q
Q2 20252024-06-30-3.782025-08-1410-Q
Q1 20252024-03-31-2.622025-05-1510-Q
FY 20242023-12-31-9.162025-03-2410-K
Q3 20242023-09-30-7.232024-11-1410-Q
Q2 20242023-06-30-4.862024-08-1210-Q
Q1 20242023-03-31-2.782024-05-1310-Q
FY 20232022-12-31-15.032024-03-2510-K
Q3 20232022-09-30-0.782023-11-1310-Q
Q2 20232022-06-30-0.492023-08-1410-Q

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.